Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Twice-daily blood thinner without routine monitoring. | Classic blood thinner monitored by INR tests. |
| Body system | Blood & Clotting | Blood & Clotting |
| Drug class | Direct oral anticoagulants | Vitamin K antagonists |
| Supply | Prescription only | Prescription onlyWHO essential medicine |
| Main uses | Stroke prevention in atrial fibrillation, Deep vein thrombosis and pulmonary embolism, Clot prevention after hip or knee replacement | Atrial fibrillation stroke prevention, Deep vein thrombosis and pulmonary embolism, Mechanical heart valves |
| How it works | Blocks one key clotting protein directly. | Stops the liver using vitamin K to make clotting proteins. |
| Starts working | 3–4 hours | Full effect takes 3–5 days |
| Half-life | About 12 hours | 20–60 hours (average ~40) |
| Typical adult dose | AF: 5 mg twice a day (2.5 mg if two of: age ≥80, weight ≤60 kg, poor kidney function). Clot treatment: 10 mg twice a day for 7 days, then 5 mg twice a day. | Individual — adjusted to keep INR usually between 2 and 3 (higher for some valves). |
| Forms | Tablet | Tablet (colour-coded strengths) |
| Common side effects | Bruising, Nosebleeds, Heavy periods | Bruising, Nosebleeds, Bleeding gums |
| Serious side effects | Major bleeding, Bleeding in the brain (less than with warfarin) | Major bleeding (blood in urine or stool, vomiting blood, severe headache), Skin necrosis (rare) |
| Don't take if | Active major bleeding; Severe liver disease with clotting abnormalities; Mechanical heart valve; Taking strong CYP3A4 and P-gp inhibitors (ketoconazole, ritonavir) without review | Pregnancy (especially first trimester); Active bleeding or severe bleeding risk; Severe liver disease; Recent major surgery or stroke with bleeding |
| Alcohol | Best to limit. Alcohol raises bleeding risk. | Best to limit. Binge drinking changes INR unpredictably and increases bleeding risk; keep intake modest and consistent. |
| Pregnancy | Usually avoidedNot used in pregnancy; low-molecular-weight heparin is preferred. | Usually avoidedCauses birth defects in the first trimester; heparin is used instead. |
| Breastfeeding | Usually avoidedAvoid. | Generally considered safeSafe while breastfeeding. |
| In use since | 2012 | 1954 |
| Brand names | United States: EliquisUnited Kingdom: EliquisIndia: Eliquis, Apigat | United States: Coumadin, JantovenUnited Kingdom: MarevanIndia: Warf, Uniwarfin |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | B01AF02 | B01AA03 |
Taken together
- MajorApixaban + Warfarin: Double anticoagulation — serious bleeding risk
Two blood thinners together greatly increase the risk of major bleeding.